Sector Update: Healthcare Stocks Edge Lower Late Afternoon

03:53 PM EST, 11/06/2026 (MT Newswires) -- Healthcare stocks edged lower late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding about 0.1%. The iShares Biotechnology ETF (IBB) rose 1.9%. In corporate news, Moderna (MRNA) raised its full-year revenue growth outlook on Friday and swung to a surprise Q3 profit year over year amid strong international sales of its COVID-19 vaccine. Its shares jumped past 6%. Natera (NTRA) shares were falling past 12%, a day after the company posted a wider-than-expected Q3 loss. Eli Lilly (LLY) and Hims & Hers Health (HIMS) said they signed an agreement to expand patient access to Eli Lilly's weight loss medicines Zepbound and Foundayo. Hims & Hers shares gained nearly 8%, and Lilly was down 0.1%. Novartis (NVS) said testing has linked two tumor cases to its Zolgensma gene therapy, which treats spinal muscular atrophy, a rare genetic disease that causes progressive muscle weakness, Bloomberg reported. Novartis shares were up 0.2%.